Global X Defense Tech ETF vs 22nd Century Group Inc — how do they compare? Global X Defense Tech ETF trades at $59.87 (market cap $6.29B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Global X Defense Tech ETF is far larger — about 10117.9× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (45,625 versus 1,133,252). Which is the better fit depends on your goals — on Pluang, investors hold Global X Defense Tech ETF for 44 Days and 22nd Century Group Inc for 32 Days on average.
| SHLD | XXII | |
|---|---|---|
Market Cap | $6.29B | $621.67K |
Volume | 1,133,252 | 45,625 |
Sector | Sector/Thematic | Consumer Staples |
52-Week High | $78.02 | $483.00 |
52-Week Low | $58.20 | $0.80 |
Typical Hold Time | 44 Days | 32 Days |
Enterprise Value | — | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
SHLD, the Global X Defense Tech ETF, trades at $59.19, up 0.77% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower, while RSI levels suggest potential oversold conditions. The fund focuses on defense technology and cybersecurity, benefiting from rising global defense budgets, as highlighted by recent institutional buying and positive news flow on European rearmament efforts.
The outlook for SHLD is supported by geopolitical tailwinds and institutional accumulation, but near-term technical weakness and reliance on defense spending cycles pose risks. Investors gain exposure to innovative defense firms, yet must monitor budget approvals and market volatility.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →